4

FORM 4 SUBMISSION

Company: Viridian Therapeutics, Inc.\DE
Filed: November 16, 2022
Period of Report: November 15, 2022
Accession Number: 0000899243-22-036044

View Document ↗ View on SEC.gov ↗